BM Technologies’s Earnings: A Preview

BM Technologies (AMEX:BMTX) is set to give its latest quarterly earnings report on Monday, 2023-03-27. Here’s what investors…

BM Technologies (AMEX:BMTX) is set to give its latest quarterly earnings report on Monday, 2023-03-27. Here’s what investors need to know before the announcement.

Analysts estimate that BM Technologies will report an earnings per share (EPS) of $-0.32.

BM Technologies bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.37, which was followed by a 8.67% drop in the share price the next day.

Here’s a look at BM Technologies’s past performance and the resulting price change:

Quarter Q3 2022 Q2 2022 Q1 2022 Q4 2021
EPS Estimate 0.30 0.14
EPS Actual -0.07 0.15 0.36 0.26
Price Change % -8.67% 3.85% 6.61% -4.05%

Stock Performance

Shares of BM Technologies were trading at $3.45 as of March 23. Over the last 52-week period, shares are down 57.48%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for BM Technologies visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called "a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets." "Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world," Sosiak said. "As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis."

LOVE